PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of “Hold” by Analysts
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the sixteen analysts that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a sell rating, six have given a hold rating, six have assigned a buy rating and one has given […]
More Stories
Bowlero Corp. (NYSE:BOWL) Receives Consensus Rating of “Moderate Buy” from Analysts
Shares of Bowlero Corp. (NYSE:BOWL – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight...
dentalcorp Holdings Ltd. (TSE:DNTL) Receives Average Recommendation of “Buy” from Brokerages
dentalcorp Holdings Ltd. (TSE:DNTL – Get Free Report) has been given a consensus rating of “Buy” by the nine brokerages...
Wyndham Hotels & Resorts, Inc. (NYSE:WH) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Wyndham Hotels & Resorts, Inc. (NYSE:WH – Get Free Report) have been given an average recommendation of “Moderate...
Catalent, Inc. (NYSE:CTLT) Receives $58.08 Average PT from Brokerages
Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have earned an average recommendation of “Hold” from the seven analysts...
HP Inc. (NYSE:HPQ) Receives $35.55 Consensus PT from Analysts
Shares of HP Inc. (NYSE:HPQ – Get Free Report) have received an average recommendation of “Hold” from the twelve brokerages...
Salesforce, Inc. (NYSE:CRM) Receives $306.00 Consensus Target Price from Analysts
Salesforce, Inc. (NYSE:CRM – Get Free Report) has earned an average rating of “Moderate Buy” from the thirty-seven analysts that...